Nosocomial transmission of c. difficile in English hospitals from patients with symptomatic infection

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Van Kleef, Esther ^a,b   Gasparrini, Antonio ^a   Guy, Rebecca ^b   Cookson, Barry ^c   Hope, Russell ^b   Jit, Mark ^a,b   Robotham, Julie V ^b   Deeny, Sarah R ^b   Edmunds, W John ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; SEASONAL VARIATION; UNITED KINGDOM; BIOLOGICAL MODEL; CLOSTRIDIUM INFECTION; CROSS INFECTION; EPIDEMIOLOGY; HOSPITAL; MICROBIOLOGY; PEPTOCLOSTRIDIUM DIFFICILE; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; TEACHING HOSPITAL; TRANSMISSION;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; ENGLAND; HOSPITALS; HOSPITALS, TEACHING; HUMANS; MODELS, BIOLOGICAL;

EID: 84903125095     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099860     Document Type: Article

References (41)

1. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW (2010) Economic healthcare costs of Clostridium difficile infection: a systematic review. Journal of Hospital Infection 74: 309-318.
2. Dubberke ER, Olsen MA. (2012) Burden of Clostridium difficile on the Healthcare System. Clinical Infectious Diseases 55: S88-S92. doi:10.1093/cid/cis335.
3. Public Health England (former Health Protection Agency) (2012) Mandatory surveillance of Clostridium difficile. PHE website. Available: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb-C/1179746015058. Accessed 2013 Mar 20.
4. Wilcox MH, Shetty N, Fawley WN, Shemko M, Coen P, et al. (2012) Changing Epidemiology of Clostridium difficile Infection Following the Introduction of a National Ribotyping-Based Surveillance Scheme in England. Clinical infectious diseases 55. doi:10.1093/cid/cis614.
5. Walker a S, Eyre DW, Wyllie DH, Dingle KE, Harding RM, et al. (2012) Characterisation of Clostridium difficile Hospital Ward-Based Transmission Using Extensive Epidemiological Data and Molecular Typing. PLoS medicine 9: e1001172. doi:10.1371/journal.pmed.1001172.
6. Didelot X, Eyre D, Cule M, Ip C, Ansari A, et al. (2012) Microevolutionary analysis of Clostridium difficile genomes to investigate transmission. Genome Biology 13: R118. doi:10.1186/gb-2012-13-12-r118.
7. Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, et al. (2013) Diverse Sources of C. difficile Infection Identified on Whole-Genome Sequencing. New England Journal of Medicine 369: 1195-1205. doi:10.1056/NEJMoa1216064.
8. Public Health England (former Health Protection Agency) (2012) English National Point Prevalence Survey on Healthcare-associated Infections and Antimicrobial Use, 2011 - preliminary data. London.
9. Goldenberg SD, French GL (2011) Diagnostic testing for Clostridium difficile: a comprehensive survey of laboratories in England. The Journal of hospital infection 79: 4-7. doi:10.1016/j.jhin.2011.03.030.
10. Lewis S, Heaton K (1997) Stools form scale as a usefule guide to intestinal transit time. Scandinavian Journal of Gastroenterology 32: 920-924. (Pubitemid 27382038)
11. Department of Health (2012) Updated guidance on the diagnosis and reporting of Clostridium difficile.
12. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection control and hospital epidemiology 31: 431-455. doi:10.1086/651706.
13. Goldstein H (2010) Multilevel Statistical Models. 4th ed. Chichester: Wiley-Blackwell.
14. Snijder TAB, Bosker RJ (2012) Multilevel analysis: An introduction to basic and advanced multilevel modeling. 2nd ed. London, England: SAGE publications.
15. Archibald LK, Banerjee SN, Jarvis WR (2004) Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. The Journal of infectious diseases 189: 1585-1589. (Pubitemid 38648285)
16. Polgreen P, Yang M, Bohnett L, Cavanaugh J (2010) A Time-Series Analysis of Clostridium difficile and Its Seasonal Association with Influenza. Infection Control Hosp Epidemiol 31: 382-387. doi:10.1086/651095.A.
17. Gilca R, Fortin E, Frenette C, Longtin Y, Gourdeau M (2012) Seasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada. Antimicrobial agents and chemotherapy 56: 639-646. doi:10.1128/AAC.05411-11.
18. Wood SN (2006) Generalized Additive Models: an introduction with R. 1st ed. London: Chapman and Hall/CRC.
19. Pinheiro JC, Bates DM (2000) Mixed-Effects Models in S and S-PLUS. New York: Springer.
20. Intelligence dr F (2013) Hospital guide. Available: http://www. drfosterhealth.co.uk/hospital-guide/.
21. Söderlund N, Milne R, Gray A, Raftery J (1995) Differences in hospital casemix, and the relationship between casemix and hospital costs. Journal of public health medicine 17: 25-32.
22. Hsu J, Abad C, Dinh M, Safdar N (2010) Prevention of endemic healthcare-associated Clostridium difficile infection: reviewing the evidence. American Journal of Gastroenterology 105: 2327-39; quiz 2340.
23. Starr JM, Martin H, McCoubrey J, Gibson G, Poxton IR (2003) Risk factors for Clostridium difficile colonisation and toxin production. Age and ageing 32: 657-660. (Pubitemid 37461575)
24. Thomas C, Stevenson M, Riley TV (2003) Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. Journal of Antimicrobial Chemotherapy 51: 1339-1350. (Pubitemid 36748921)
25. McFarland LV, Mulligan ME, Kwok RYY, Stam WE (1989) Nosocomial acquisition of Clostridium difficile infection. New England Journal of Medicine 321: 190.
26. Samore MH, Venkataraman L, Degirolami PC, Arbeit RD, Karchmer AW (1996) Clinical and Molecular Epidemiology of Sporadic and Clustered Cases of Nosocomial Clostridium difficile Diarrhea. the American Journal of Medicine 100: 32-40.
27. Kaatz G, Gitlin S, Schaberg D, Wilson KH, Kauffman CA, et al. (1988) Acquisition of clostridium difficile from the hospital environment. American Journal of Epidemiology 127: 1289-1294.
28. Kim K, Fekety R, Batts DH, Brown D (1981) Isolation of Clostridium difficile from the Environment and Contacts of Patients with Antibiotic-Associated Colitis. The Journal of infectious diseases 143: 42-50. (Pubitemid 11152596)
29. Guerrero DM, Becker JC, Eckstein EC, Kundrapu S, Deshpande A, et al. (2013) Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. The Journal of hospital infection: 2-5. doi:10.1016/j.jhin.2013.07. 002.
30. Ricciardi R, Nelson J, Griffith JL, Concannon TW (2012) Do admissions and discharges to long-term care facilities influence hospital burden of Clostridium difficile infection? The Journal of hospital infection 80: 156-161. doi:10.1016/j.jhin.2011.11.002.
31. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RLP, et al. (2007) Asymptomatic Carriers Are a Potential Source for Transmission of Epidemic and Nonepidemic Clostridium difficile Strains among Long-Term Care Facility Residents. Clinical Infectious Diseases 45: 992-998. doi:10.1086/521854. (Pubitemid 47580347)
32. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, et al. (2011) The Epidemiology of Community-Acquired Clostridium difficile Infection: A Population-Based Study. The American Journal of Gastroenterology 107: 89-95. doi:10.1038/ajg.2011.398.
33. Kamboj M, Khosa P, Kaltsas A, Babady NE, Son C, et al. (2011) Relapse versus reinfection: surveillance of Clostridium difficile infection. Clinical infectious diseases 53: 1003-1006. doi:10.1093/cid/cir643.
34. Fekety R, McFarland L V, Surawicz CM, Greenberg RN, Elmer GW, et al. (1997) Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 24: 324-333.
35. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, et al. (2013) Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection. Clinical infectious diseases 56: 1589-1600. doi:10.1093/cid/cit127.
36. Vernaz N, Hill K, Leggeat S, Nathwani D, Philips G, et al. (2009) Temporal effects of antibiotic use and Clostridium difficile infections. The Journal of antimicrobial chemotherapy 63: 1272-1275. doi:10.1093/jac/dkp128.
37. Eyre DW, Griffiths D, Vaughan A, Golubchik T, Acharya M, et al. (2013) Asymptomatic Clostridium difficile colonisation and onward transmission. PloS one 8: e78445. doi:10.1371/journal.pone.0078445.
38. Gould LH, Limbago B (2010) Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 51: 577-582. doi:10.1086/655692.
39. Bootsma MCJ, Bonten MJM, Nijssen S, Fluit a C, Diekmann O (2007) An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. American journal of epidemiology 166: 841-851. doi:10.1093/aje/ kwm149. (Pubitemid 47428903)
40. McBryde ES, Pettitt AN, Cooper BS, McElwain DLS (2007) Characterizing an outbreak of vancomycin-resistant enterococci using hidden Markov models. Journal of the Royal Society Interface 4: 745-754. (Pubitemid 47204173)
41. Forrester ML, Pettitt AN, Gibson GJ (2007) Bayesian inference of hospital-acquired infectious diseases and control measures given imperfect surveillance data. Biostatistics 8: 383-401. (Pubitemid 46569598)